Serum Protein Biomarkers Can Predict Worsening Knee Osteoarthritis
The researchers said that being able to predict who is at risk of knee osteoarthritis progression will aid in the development of new treatments.
The new partnership will support the analysis of glycans in 30,000 human samples by the end of 2021.
Metabolic Signature Reported to Distinguish Early-Stage Ovarian Cancer
Georgia Tech researchers used high-performance mass spectrometry to uncover a highly accurate 16-marker signature that identifies women with ovarian cancer.
Waters Posts 2 Percent Rise in Q1 Revenues Driven by Increased Instrument Sales
NEW YORK (GenomeWeb News) – Waters today reported that its revenues in the first quarter were up 2 percent year over year, driven by a resurgence in instrument sales, particularly mass spectrometers.
Waters Offering Acquity UPLC with Spark Holland SPE Technology
NEW YORK (GenomeWeb News) – Waters is offering its Acquity UPLC System with online solid phase extraction technology from Spark Holland under a deal announced today between the firms.
Apr 29, 2011
Jan 28, 2011
Jan 7, 2011
May 7, 2010
Oct 20, 2009
FDA Buys Nine Waters Acquity UPLC Systems
Jun 25, 2009